All the information you'd like to see will be presented, but not in TLD. I would hope it will be seen here: https://www.soc-neuro-onc.org/SNO/News/2020_SNO_Annual_Meeting.aspx
Hopefully they've submitted a placeholder abstract which will permit them to discuss the entire trial in depth. It's too early to say if this will be a real conference, or a virtual one, but I suspect it will become virtual as the date approaches unless miraculously a vaccine is available for Covid-19 well before it is scheduled to occur.
ASCO was virtual this year, I expect most others will be, if not they may be rescheduled, but frankly I believe that many are seeing benefits to virtual conferences and even after covid has disappeared, I wouldn't be surprised if conferences will have options, you may attend, or you may enroll virtually. My Dr. at City of Hope has attended many ASH and ASCO conferences, but I suspect that if he's not presenting, he'd choose the virtual option if available. While I think there is nothing like speaking directly with others in the field, I believe that people are learning they can express views in Zoom conferences, and they can be constructive.
It's after presentation of the data at SNO or other conference that the data you expect to see in TLD will become available to investors, as after such a conference, it is considered to be peer reviewed.